New research suggests that δ-receptor agonists regulate intestinal motility and relieve abdominal pain in a mouse model of irritable bowel syndrome, potentially offering a novel CNS-targeted ...
StockNews.com began coverage on shares of Trevena (NASDAQ:TRVN – Free Report) in a research report sent to investors on Friday. The brokerage issued a sell rating on the biopharmaceutical company’s ...
For patients with psychiatric conditions from addiction to mood disorders such as depression, disrupted sleep can often ...
Mizzou stayed competitive until late in the game against No. 6-ranked LSU, but like a majority of the conference games that came before it this season, MU left the court with a 71-60 loss to coach ...
A new congressionally mandated report examines how opioid and benzodiazepine prescribing between 2007 and 2019 impacted ...
Researchers at University of the Pacific in Stockton have developed a long-acting opioid overdose-reversal drug-delivery system that could save lives.
HealthDay on MSN5d
Distribution of Opioid Meds Lower in Majority Non-White CommunitiesHealthDay News — Distribution of prescribed opioid analgesics is lower in majority non-White versus majority White communities across all levels of socioeconomic deprivation, according to a study ...
Despite an increase in the use of medication for opioid use disorder in older adults from 2017 to 2022, disparities persist; ...
In the latest market close, Micron (MU) reached $94.51, with a +0.97% movement compared to the previous day. The stock's change was more than the S&P 500's daily gain of 0.36%. At the same time ...
In this article, we are going to take a look at where Micron Technology, Inc. (NASDAQ:MU) stands against other best big tech stocks to buy according to analysts. Big Tech comprises some of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results